BofA analyst Kevin Fischbeck raised the firm’s price target on Cigna to $350 from $320 and keeps a Buy rating on the shares after updating the firm’s model following the company’s quarterly report and call. The firm, which is raising its revenue forecast but maintaining its EPS estimates, sees better visibility into trends and potential upside on commercial and PBM earnings in the near-term.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CI:
